Abstract

The thulium laser has several properties that confer some theoretical advantages over other lasers used for the treatment of BPH such as a relatively small zone of thermal damage. In ex vivo animal studies comparing the KTP and thulium lasers, similar hemostatic properties were observed with a shallower coagulation zone (Wendt-Nordahl et al. J Endourol. 2008;22:1041). Two main techniques for laser resection and vapoenucleation have been described: ThuVEP and TmLRP (Xia et al. Eur Urol. 2008;53:383, Bach et al. World J Urol. 2007;25:257). Studies using the 70–120-W thulium laser systems demonstrate good efficacy of these procedures with low morbidity and few complications in mostly small- and medium-sized prostates (Gross et al. Eur Urol. 2012;63:859). Safety and efficacy has also been demonstrated in patients taking oral anticoagulation (Macchione et al. Int Urol Nephrol. 2013;45:1545–51). Comparative studies have been published comparing thulium laser prostatectomy to monopolar TURP, bipolar TURP, and HoLEP. Compared to all these techniques, thulium laser prostatectomy had a longer operative time and demonstrated superior blood loss compared to TURP techniques. Short- and intermediate-term improvements in IPSS, QoL, Qmax, and PVR were similar across techniques. Overall thulium laser resection and vapoenucleation, and enucleation techniques appear safe and effective with low morbidity. Further comparative and long-term studies are needed for this promising technology, particularly in larger prostates.

Keywords

Catheter Adenocarcinoma Heparin Warfarin Mannitol 

References

  1. 1.
    Fried N, Murray K. High-power thulium fiber laser ablation of urinary tissues at 1.94. J Endourol. 2005;19:25.PubMedCrossRefGoogle Scholar
  2. 2.
    Pierce MC, Jackson SD, Dickinson MR, et al. Laser–tissue interaction with a high-power 2-μm fiber laser: preliminary studies with soft tissue. Lasers Surg Med. 1999;25:407.PubMedCrossRefGoogle Scholar
  3. 3.
    Sumiyoshi T, Sekita H, Arai T, et al. High-power continuous-wave 3- and 2μm cascade Ho3+:ZBLAN fiber laser and its medical applications. EEE J Sel Top Quant Electr. 1999;5:936.CrossRefGoogle Scholar
  4. 4.
    Pierce M, Jackson S, Dickinson M, et al. Laser–tissue interaction with a continuous wave 3-μm fibre laser: preliminary studies with soft tissue. Lasers Surg Med. 2000;26:491.PubMedCrossRefGoogle Scholar
  5. 5.
    El-Sherif A, King T. Soft and hard tissue ablation with short- pulse high peak power and continuous thulium-silica fibre lasers. Lasers Med Sci. 2003;18:139.PubMedCrossRefGoogle Scholar
  6. 6.
    Schomacker K, Domankevitz Y, Flotte T, et al. Co:MgF2 laser ablation of tissue: effect of wavelength on ablation threshold and thermal damage. Lasers Surg Med. 1991;11:141.PubMedCrossRefGoogle Scholar
  7. 7.
    Hai M, Malek R. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol. 2003;17:93.PubMedCrossRefGoogle Scholar
  8. 8.
    Tan A, Gilling P, Kennett K, et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003;170:1270.PubMedCrossRefGoogle Scholar
  9. 9.
    Wendt-Nordahl G, Huckele S, Honeck P, et al. Systemic evaluation of a recently introduced 2-μm continuous-wave thulium laser for vaporesection of the prostate. J Endourol. 2008;22:1041.PubMedCrossRefGoogle Scholar
  10. 10.
    Xia S, Zhuo J, Sun X, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol. 2008;53:383.CrossRefGoogle Scholar
  11. 11.
    Bach T, Hermann T, Ganzer R, et al. Revolix vaporesection of the prostate: initial results of 54 patients with 1-year follow-up. World J Urol. 2007;25:257.PubMedCrossRefGoogle Scholar
  12. 12.
    Bach T, Wendt-Nordahl G, Michel M, et al. Feasibility and efficacy of thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol. 2009;27:541.PubMedCrossRefGoogle Scholar
  13. 13.
    Bach T, Hermann T, Hacker A, et al. Thulium:yttrium-aluminum-garnet laser prostatectomy in men with refractory urinary retention. BJU Int. 2009;104:361.PubMedCrossRefGoogle Scholar
  14. 14.
    Gross A, Netsch C, Knipper S, et al. Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol. 2012;63:859.PubMedCrossRefGoogle Scholar
  15. 15.
    Netsch C, Bach T, Hermann T, et al. Thulium:YAG VapoEnucleation of the prostate in large glands: a prospective comparison using 10- and 120-W 2-μm lasers. Asian J Androl. 2012;14:325.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Macchione L, Mucciardi G, Gali A, et al. Efficacy and safety of prostate vaporesection using a 120-W 2-μm continuous-wave Tm:YAG (RevoLix 2) in patients on continuous oral anticoagulant or antiplatelet therapy. Int Urol Nephrol. 2013;45:1545–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Netsch C, Bach T, Hermann T, et al. Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach. World J Urol. 2013;31:1231.PubMedCrossRefGoogle Scholar
  18. 18.
    Peng B, Wang G, Zheng J, et al. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia. BJU Int. 2013;111:633.PubMedCrossRefGoogle Scholar
  19. 19.
    Yang Z, Wang X, Liu T. Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up. Urology. 2013;81:396.PubMedCrossRefGoogle Scholar
  20. 20.
    Zhang F, Shao Q, Hermann T, et al. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology. 2012;79:869.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Section of Urology, Department of SurgeryUniversity of Chicago Medical Center and Mount Sinai HospitalChicagoUSA

Personalised recommendations